ET - 医索

找到约 1487 条结果

Lorlatinib vs Crizotinib in Treatment-NaivePatients With Advanced ALK Non-SmallCell Lung Cancer 5-Year Progression-FreeSurvival and Safety From the CRoWN Study

医客学院 - 会议报告集

Global Retrospective Study Comparing Consolidation ALK TKl to Durvalumab or Observation after Chemoradiation in Unresectable Locally Advanced ALK NSCLC

医客学院 - 会议报告集

Feasibility and safety of neoadjuvant nivolumab and chemotherapy for resectable diffuse pleural mesotheliomas (DPM) Results of a prospective pilot study

医客学院 - 会议报告集

ETOP 13-18 BEAT-meso

医客学院 - 会议报告集

EFFICACY AND SAFETY OF TALETRECTINIB INPATIENTS WITH ADVANCED OR METASTATICROS1 NON-SMALL CELL LUNG CANCER THEPHASE 2 TRUST-I STUDY

医客学院 - 会议报告集

EFFICACY AND SAFETY OF SIGVOTATUGVEDOTIN, AN INVESTIGATIONAL ADC, IN NSCLCUPDATED PHASE 1 RESULTS(SGNB6A-001)

医客学院 - 会议报告集

Efficacy and Safety of Erdafitinib in Adults WithNSCLC and Prespecified Fibroblast Growth FactorReceptor Alterations in the Phase 2 Open-labelSingle-arm RAGNAR Trial

医客学院 - 会议报告集

ctDNA-Lung-DETECT rate of ctDNA detection and outcomes for clinical stagel NSCLC

医客学院 - 会议报告集

Updated results from the Phase 1b2 HERKULES-3 studyERAS-007 plus encorafenib and cetuximab (Ec)inpatients (pts)with EC-naive metastatic BRAF V600Ecolorectal cancer (CRC)

医客学院 - 会议报告集

Time dependency for HPV ctDNAdetection as a prognostic biomarkerfor anal cancer

医客学院 - 会议报告集

今日实时热搜